** = Publikationen gelistet in SCI/SSCI/Pubmed
** Cejka, V; Riepl, H; Schwegel, N; Kolesnik, E; Zach, D; Santner, V; Höller, V; Schweighofer, N; Obermayer-Pietsch, B; Pieber, T; Morbach, C; Frantz, S; Zirlik, A; von, Lewinski, D; Störk, S; Posch, F; Ablasser, K; Verheyen, N
Prognostic impact of gait speed, muscle strength and muscle mass in chronic heart failure-A prospective cohort study.
ESC Heart Fail. 2025; 12(3):2113-2124
Doi: 10.1002/ehf2.15221
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Debonnaire, P; Dujardin, K; Verheyen, N; Pouleur, AC; Droogmans, S; Claeys, M; Bohyn, A; Bogaerts, K; El, Haddad, M; Christiaen, E; Wyseure, N; Zach, DK; Buytaert, L; Jacobs, A; Buysschaert, I; Trenson, S; Van, Hoeyweghen, R; Tavernier, R
Tafamidis in octogenarians with wild-type transthyretin cardiac amyloidosis: an international cohort study.
Eur Heart J. 2025;
Doi: 10.1093/eurheartj/ehae923
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwegel, N; Strohhofer, C; Kolesnik, E; Oltean, S; Hüttmair, A; Pipp, C; Benedikt, M; Verheyen, N; Gollmer, J; Ablasser, K; Wallner, M; Santner, V; Tripolt, N; Pferschy, P; Zechner, P; Alber, H; Siller-Matula, JM; Kopp, K; Zirlik, A; Aziz, F; Sourij, H; von, Lewinski, D
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial.
Clin Res Cardiol. 2025; 114(5):629-639
Doi: 10.1007/s00392-024-02523-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Desai, MY; Nissen, SE; Abraham, T; Olivotto, I; Garcia-Pavia, P; Lopes, RD; Verheyen, N; Wever-Pinzon, O; Wolski, K; Jaber, W; Mitchell, L; Davey, D; Myers, J; Rano, T; Bhatia, V; Zhong, Y; Carter-Bonanza, S; Florea, V; Aronson, R; Owens, AT, , ODYSSEY-HCM, Investigators
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Design, Rationale, and Baseline Characteristics of ODYSSEY-HCM.
JACC Heart Fail. 2025; 13(2):358-370
Doi: 10.1016/j.jchf.2024.11.013
Web of Science
PubMed
FullText
FullText_MUG
** Höller, V; Santner, V; Schmid, J; Zirlik, A; Verheyen, N
Variant cardiac transthyretin amyloidosis presenting as hypertrophic cardiomyopathy with left ventricular outflow tract obstruction: a case report
EUR HEART J-CASE REP. 2025; 9(2): ytaf029
Doi: 10.1093/ehjcr/ytaf029
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sterniste, G; Hackner, K; Moazedi-Fürst, F; Grasl, M; Idzko, M; Shao, G; Guttmann-Ducke, C; Talakić, E; Prosch, H; Lohfink-Schumm, S; Gabriel, M; Lim, C; Hochreiter, J; Bucher, B; Böckle, BC; Kiener, HP; Duftner, C; Kastrati, K; Rath, E; Funk, M; Löffler-Ragg, J; Steinmaurer, M; Kovacs, G; Verheyen, N; Flick, H; Antlanger, M; Traxler, G; Tatscher, E; Zwick, RH; Lang, D
[Not Available].
WIEN KLIN WOCHENSCHR. 2025; 137(1-2): 62-63.
Doi: 10.1007/s00508-024-02487-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gil-Redondo, R; Conde, R; Bruzzone, C; Seco, ML; Bizkarguenaga, M; González-Valle, B; de, Diego, A; Laín, A; Habisch, H; Haudum, C; Verheyen, N; Obermayer-Pietsch, B; Margarita, S; Pelusi, S; Verde, I; Oliveira, N; Sousa, A; Zabala-Letona, A; Santos-Martin, A; Loizaga-Iriarte, A; Unda-Urzaiz, M; Kazenwadel, J; Berezhnoy, G; Geisler, T; Gawaz, M; Cannet, C; Schäfer, H; Diercks, T; Trautwein, C; Carracedo, A; Madl, T; Valenti, L; Spraul, M; Lu, SC; Embade, N; Mato, JM; Millet, O
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics.
Cardiovasc Diabetol. 2024; 23(1): 272
Doi: 10.1186/s12933-024-02363-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Horstmann, H; Michel, NA; Sheng, X; Hansen, S; Lindau, A; Pfeil, K; Fernández, MC; Marchini, T; Winkels, H; Mitre, LS; Abogunloko, T; Li, X; Mwinyella, TB; Gissler, MC; Bugger, H; Heidt, T; Buscher, K; Hilgendorf, I; Stachon, P; Piepenburg, S; Verheyen, N; Rathner, T; Gerhardt, T; Siegel, PM; Oswald, WK; Cohnert, T; Zernecke, A; Madl, J; Kohl, P; Foks, AC; von, Zur, Muehlen, C; Westermann, D; Zirlik, A; Wolf, D
Cross-species single-cell RNA sequencing reveals divergent phenotypes and activation states of adaptive immunity in human carotid and experimental murine atherosclerosis.
Cardiovasc Res. 2024; 120(14): 1713-1726.
Doi: 10.1093/cvr/cvae154
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwegel, N; Toferer, C; Zach, DK; Santner, V; Höller, V; Lugitsch, J; Wallner, M; Gollmer, J; Aziz, F; von, Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N
Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study.
J Clin Med. 2024; 13(19):
Doi: 10.3390/jcm13195966
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwegel, N; Zach, D; Peikert, A; Santner, V; Höller, V; Gollmer, J; Späth, J; Riepl, H; Rainer, PP; Wallner, M; Pilz, S; Zirlik, A; von, Lewinski, D; Ablasser, K; Verheyen, N; Kolesnik, E
The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure-A Prospective Study.
J Clin Med. 2024; 13(7): 1930
Doi: 10.3390/jcm13071930
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Skok, K; Zacharias, M; Verheyen, N; Hatzl, S; Scholz, L; Langner, C; Hoefler, G; Vagena, FR
Myeloid sarcoma of the heart-A clinicopathological correlation.
Wien Klin Wochenschr. 2024;
Doi: 10.1007/s00508-024-02478-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sterniste, G; Hackner, K; Moazedi-Fürst, F; Grasl, M; Izdko, M; Shao, G; Guttmann-Ducke, C; Talakić, E; Prosch, H; Lohfink-Schumm, S; Gabriel, M; Lim, C; Hochreiter, J; Bucher, B; Böckle, BC; Kiener, HP; Duftner, C; Kastrati, K; Rath, E; Funk, M; Löffler-Ragg, J; Steinmaurer, M; Kovacs, G; Verheyen, N; Flick, H; Antlanger, M; Traxler, G; Tatscher, E; Zwick, RH; Lang, D
[Position paper of the Austrian Society for Rheumatology and the Austrian Society for Pneumology on the diagnosis and treatment of sarcoidosis 2024].
Wien Klin Wochenschr. 2024; 136(Suppl 17): 669-687.
Doi: 10.1007/s00508-024-02444-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Auer, J; Bonaros, N; Buchacher, T; Dalos, D; Grimm, M; Mayr, A; Rab, A; Reinstadler, S; Scherr, D; Toth, GG; Weber, T; Zach, DK; Zaruba, MM; Zimpfer, D; Rainer, PP; Pölzl, G
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.
Wien Klin Wochenschr. 2024; 136(Suppl 15): 571-597.
Doi: 10.1007/s00508-024-02442-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Schmid, J; Kolesnik, E; Schwegel, N; Späth, J; Kattnig, L; Riepl, H; Zach, D; Santner, V; Höller, V; Pilz, S; Tomaschitz, A; Fuchsjäger, M; Fahrleitner-Pammer, A; Dimai, HP; Obermayer-Pietsch, B; Fruhwald, F; Scherr, D; Zirlik, A; von, Lewinski, D; Ablasser, K
Prevalence and prognostic impact of bone disease in chronic heart failure with reduced ejection fraction.
ESC Heart Fail. 2024; 11(3):1730-1738
Doi: 10.1002/ehf2.14741
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** von, Lewinski, F; Quehenberger, F; Sacherer, M; Taucher, V; Strohhofer, C; Ablasser, K; Verheyen, N; Sourij, C; Kainz, A; Wünsch, G; Berghold, A; Berghaus, TM; Kanoun, Schnur, SS; Zirlik, A; von, Lewinski, D
Air Pollution and Myocardial Infarction-A New Smoker's Paradox?
J Clin Med. 2024; 13(23):
Doi: 10.3390/jcm13237324
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zach, DK; Schwegel, N; Santner, V; Winkelbauer, L; Hoeller, V; Kolesnik, E; Gollmer, J; Seggewiss, H; Batzner, A; Perl, S; Wallner, M; Reiter, U; Rainer, PP; Zirlik, A; Ablasser, K; Verheyen, N
Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
Int J Cardiol. 2024; 399:131661
Doi: 10.1016/j.ijcard.2023.131661
Web of Science
PubMed
FullText
FullText_MUG
** Schwegel, N; Verheyen, N
Update on the Treatment of LVOT Obstruction in HOCM
J KARDIOL. 2024; 31(7-8):
Web of Science
** Verheyen, N; Bugger, H
ESC Cardiomyopathy Guidelines 2023 - An Overview
J KARDIOL. 2024; 31(9-10):
Web of Science
** Debonnaire, P; Dujardin, K; Verheyen, N; Pouleur, AC; Droogmans, S; Claeys, M; El Haddad, M; Christiaen, E; Zach, D; Buytaert, L; Jacobs, A; Buysschaert, I; Trenson, S; Van Hoeyweghen, R; Tavernier, R
AI-enabled cardiac chambers volumetry in non-contrast coronary artery calcium CT scans vs. contrast-enhanced coronary CT angiography scans in the same patients
EUR HEART J. 2024; 45: ehae666206
Doi: 10.1093/eurheartj/ehae666.206
[Poster]
Web of Science
FullText
FullText_MUG
** Ponti, L; Hsu, K; Damy, T; Argüelles, EV; Verheyen, N; Keohane, D; Wang, R; Ines, M; Kumar, N; Munteanu, C; Cappelli, F
Predictors of burden in caregivers to patients with untreated transthyretin amyloid cardiomyopathy
AMYLOID. 2024; 31: S2-S2.
[Poster]
Web of Science
** Schwegel, N; Santner, ; Zach, DK; Hoeller, ; Wallner, M; Muendlein, A; Brandtner, EM; Leiherer, A; Drexel, H; Mader, A; Von Lewinski, D; Ablasser, K; Kolesnik, E; Zirlik, A; Verheyen, N
Prognostic value of circulating glypican-4 in patients with chronic heart failure with reduced ejection fraction
EUR HEART J. 2024; 45(S1):ehae666971--ESC Congress; AUG 30-SEP 02, 2024; London, UK.
Doi: 10.1093/eurheartj/ehae666.971
[Poster]
Web of Science
FullText
FullText_MUG
** Toferer, C; Schwegel, N; Santner, ; Zach, DK; Hoeller, ; Wallner, M; Gollmer, J; Aziz, F; Von Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N
Prognostic impact of SGLT2-inhibitor therapy on survival in patients with transthyretin amyloid cardiomyopathy
EUR HEART J. 2024; 45(S1):ehae6662037--ESC Congress; AUG 30-SEP 02, 2024; London, UK.
Doi: 10.1093/eurheartj/ehae666.2037
[Poster]
Web of Science
FullText
FullText_MUG
** Ungericht, M; Messner, M; Puelacher, C; Schuetz, T; Staggl, S; Zaruba, MM; Willenbacher, W; Weger, R; Rittler, S; Agis, H; Krauth, MT; Weber, T; Höller, V; Verheyen, N; Ebner, C; Strassl, I; Pichler, P; Darling, P; Pölzl, G
Prevalence and outcome of coronary artery disease in cardiac amyloidosis: a retrospective Austrian multicenter study
AMYLOID. 2024; 31: S147-S147.
[Poster]
Web of Science
** Winkelbauer, L; Santner, ; Schwegel, N; Hoeller, ; Gollmer, J; Kolesnik, E; Wallner, M; Von Lewinski, D; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Left atrial reservoir strain differentiates cardiac amyloidosis and hypertrophic cardiomyopathy
EUR HEART J. 2024; 45(S1):ehae666946--ESC Congress; AUG 30-SEP 02, 2024; London, UK.
Doi: 10.1093/eurheartj/ehae666.946
[Poster]
Web of Science
FullText
FullText_MUG
** Zach, DK; Batzner, A; Schwegel, N; Santner, ; Hoeller, ; Ablasser, K; Morbach, C; Stoerk, S; Maack, C; Reiter, U; Rainer, PP; Frantz, S; Zirlik, A; Seggewiss, H; Verheyen, N
Residual mitral leaflet length independently indicates left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
EUR HEART J. 2024; 45: ehae666098
Doi: 10.1093/eurheartj/ehae666.098
[Poster]
Web of Science
FullText
FullText_MUG
** Verheyen, N; Rainer, PP
Editorial comment regarding article: Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis.
Clin Res Cardiol. 2024;
Doi: 10.1007/s00392-024-02528-w
Web of Science
PubMed
FullText
FullText_MUG
** Achim, A; Hochegger, P; Kanoun, Schnur, SS; Moser, L; Stark, C; Pranevičius, R; Prunea, D; Schmidt, A; Ablasser, K; Verheyen, N; Kolesnik, E; Maier, R; Luha, O; Ruzsa, Z; Zirlik, A; Toth, GG
Transesophageal echocardiography-guided versus fluoroscopy-guided patent foramen ovale closure: A single center registry.
ECHOCARDIOGR-J CARD. 2023; 40(7): 657-663.
Doi: 10.1111/echo.15630
Web of Science
PubMed
FullText
FullText_MUG
** Batzner, A; Hahn, P; Morbach, C; Störk, S; Maack, C; Verheyen, N; Gerull, B; Frantz, S; Seggewiss, H
Non-invasive estimation of left ventricular systolic peak-pressure - a prerequisite to calculate myocardial work in hypertrophic obstructive cardiomyopathy.
Eur Heart J Cardiovasc Imaging. 2023;
Doi: 10.1093/ehjci/jead236
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Feuerstein, A; Schoenrath, F; Belyavskiy, E; Knierim, J; Friede, T; Placzek, M; Bach, D; Pieske-Kraigher, E; Herrmann-Lingen, C; Westenfeld, R; Roden, M; Rybczynski, M; Verheyen, N; Dörr, M; von, Haehling, S; Störk, S; Halle, M; Falk, V; Pieske, B; Edelmann, F
Supervised exercise training in patients with advanced heart failure and left ventricular assist device: A multicentre randomized controlled trial (Ex-VAD trial).
Eur J Heart Fail. 2023;
Doi: 10.1002/ejhf.3032
Web of Science
PubMed
FullText
FullText_MUG
** Jud, P; Verheyen, N; Stradner, MH; Dejaco, C; Szolar, D; Thonhofer, R; Schweiger, L; Brodmann, M; Hafner, F
Association of immunological parameters with aortic dilatation in giant cell arteritis: a cross-sectional study.
Rheumatol Int. 2023; 43(3):477-485
Doi: 10.1007/s00296-022-05186-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ponti, L; Hsu, K; Damy, T; Villacorta, E; Verheyen, N; Keohane, D; Wang, R; Ines, M; Kumar, N; Munteanu, C; Cappelli, F
Burden of untreated transthyretin amyloid cardiomyopathy on patients and their caregivers by disease severity: results from a multicenter, non-interventional, real-world study.
Front Cardiovasc Med. 2023; 10:1238843
Doi: 10.3389/fcvm.2023.1238843
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Reintar, S; Pochhacker, M; Obermayer, A; Eberhard, K; Zirlik, A; Verheyen, N; von Lewinski, D; Scherr, D; Hutz, B; Haudum, CW; Pieber, TR; Sourij, H; Obermayer-Pietsch, B
Urinary C-Peptide to Creatinine Ratio (UCPCR) as Indicator for Metabolic Risk in Apparently Healthy Adults-A BioPersMed Cohort Study
NUTRIENTS. 2023; 15(9): 2073
Doi: 10.3390/nu15092073
Web of Science
FullText
FullText_MUG
** Reintar, S; Pöchhacker, M; Obermayer, A; Eberhard, K; Zirlik, A; Verheyen, N; von, Lewinski, D; Scherr, D; Hutz, B; Haudum, CW; Pieber, TR; Sourij, H; Obermayer-Pietsch, B
Urinary C-Peptide to Creatinine Ratio (UCPCR) as Indicator for Metabolic Risk in Apparently Healthy Adults-A BioPersMed Cohort Study.
Nutrients. 2023; 15(9):
Doi: 10.3390/nu15092073
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Santner, V; Riepl, HS; Posch, F; Wallner, M; Rainer, PP; Ablasser, K; Kolesnik, E; Hoeller, V; Zach, D; Schwegel, N; Kreuzer, P; Lueger, A; Petutschnigg, J; Pieske, B; Zirlik, A; Edelmann, F; Verheyen, N
Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort.
Eur J Intern Med. 2023; 118:73-81
Doi: 10.1016/j.ejim.2023.07.027
Web of Science
PubMed
FullText
FullText_MUG
** Tandl, V; Haudum, C; Eberhard, K; Hutz, B; Foessl, I; Kolesnik, E; Zirlik, A; von, Lewinski, D; Scherr, D; Verheyen, N; Pieber, T; Obermayer-Pietsch, B
AMH in Males: Effects of Body Size and Composition on Serum AMH Levels.
J Clin Med. 2023; 12(13):
Doi: 10.3390/jcm12134478
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Batzner, A; Zach, D; Zirlik, A; Gerull, B; Frantz, S; Maack, C; Störk, S; Seggewiss, H; Morbach, C
Spatial relationship between mitral valve and ventricular septum assessed by resting echocardiography to diagnose left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Eur Heart J Cardiovasc Imaging. 2023; 24(6): 710-718.
Doi: 10.1093/ehjci/jead036
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Rainer, P
Rarely cardiomyopathies
J KARDIOL. 2023; 30(5-6): 124-129.
Web of Science
** von, Lewinski, D; Herold, L; Bachl, E; Bugger, H; Glantschnig, T; Kolesnik, E; Verheyen, N; Benedikt, M; Wallner, M; von, Lewinski, F; Schmidt, A; Harb, S; Ablasser, K; Sacherer, M; Scherr, D; Manninger-Wünscher, M; Pätzold, S; Gollmer, J; Zirlik, A; Toth, GG
Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort.
J Clin Med. 2023; 12(22):
Doi: 10.3390/jcm12226988
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Cappelli, F; Ponti, L; Hsu, K; Damy, T; Villacorta, E; Verheyen, N; Keohane, D; Wang, R; Ines, M; Kumar, N; Munteanu, C
Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy: post hoc analysis of an international survey study
EUR HEART J. 2023; 44:
[Poster]
Web of Science
** Cappelli, F; Ponti, L; Hsu, K; Damy, T; Villacorta, E; Verheyen, N; Keohane, D; Wang, R; Ines, M; Kumar, N; Munteanu, C
Burden of transthyretin amyloid cardiomyopathy in treatment-naive patients by heart failure severity: results from a large, non-interventional, real-world study
EUR J HEART FAIL. 2023; 25: 80-81.
[Poster]
Web of Science
** Cappelli, F; Ponti, L; Hsu, K; Damy, T; Villacorta, E; Verheyen, N; Keohane, D; Wang, R; Ines, M; Kumar, N; Munteanu, C
Caregiver burden by severity of patient's heart failure due to transthyretin amyloid cardiomyopathy: results from a large, non-interventional, real-world study
EUR J HEART FAIL. 2023; 25: 81-82.
[Poster]
Web of Science
** Lugitsch, J; Hoeller, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Lugitsch, J; Holler, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
WIEN KLIN WOCHENSCHR. 2023; 135: S472-S473.
[Poster]
Web of Science
FullText
** Schwegel, N; Riepl, H; Spath, J; Kolesnik, E; Zach, D; Santner, V; Holler, V; Obermayer-Pietsch, B; Schmid, J; Scherr, D; von Lewinski, D; Zirlik, A; Ablasser, K; Verheyen, N
Role of Comorbidities in Chronic Heart Failure-a prospective cohort study
WIEN KLIN WOCHENSCHR. 2023; 135: S477-S477.
Web of Science
FullText
** Strohhofer, C; Oltean, S; Huttmair, A; Pipp, C; Benedikt, M; Wallner, M; Verheyen, N; Gollmer, J; Ablasser, K; Hanfstingl-Sinz, D; Andorfer, J; Pachinger-Possl, S; Brunner, M; Rogozarski, J; Kolesnik, E
The SGLT2-inhibitor Empagliflozin improves Parameters of Diastolic Function after Myocardial Infarction measured by Echocardiography-a Single Center Sub Analysis of the EMMY-Trial
WIEN KLIN WOCHENSCHR. 2023; 135: S343-S345.
[Poster]
Web of Science
** Willenbacher, W; Agis, H; Krauth, MT; Rodriguez-Torres, C; Strassl, I; Verheyen, ND; Hoeller, V; Darling, P; Pichler, P; Rittler, S; Weger, R; Willenbacher, E
Real-World Outcomes and Treatment Patterns in AL-Amyloidosis in Austria: An Analysis from the Austrian Interdisciplinary Amyloidosis Registry (AIDA)
BLOOD. 2023; 142:
Doi: 10.1182/blood-2023-187598
Web of Science
FullText
FullText_MUG
** Winter, S; Eberhard, K; Kolesnik, E; Colantonio, C; Baranyi, A; Lind, A; Hutz, B; Pieber, T; Zirlik, A; Schmidt, A; Obermayer-Pietsch, B; Scherr, D; Ablasser, K; Von Lewinski, D; Verheyen, N
Physical capacity determines physical and mental health in patients with chronic heart failure - a case control study
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Winter, S; Eberhard, K; Kolesnik, E; Colantonio, C; Baranyi, A; Lind, A; Hutz, B; Pieber, T; Zirlik, A; Schmidt, A; Obermayer-Pietsch, B; Scherr, D; Ablasser, K; von Lewinski, L; Verheyen, N
Physical capacity determines physical and mental health in patients with chronic heart failure-a case control study
WIEN KLIN WOCHENSCHR. 2023; 135: S471-S472.
[Poster]
Web of Science
** Zach, D; Schwegel, N; Hoeller, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N
Comparing indices of systemic inflammation and cardiac phenotype between hypertensive and non-hypertensive hypertrophic cardiomyopathy
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Zach, D; Schwegel, N; Holler, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N
Comparing indices of systemic inflammation and cardiac phenotype in hypertensive and non-hypertensive hypertrophic cardiomyopathy
WIEN KLIN WOCHENSCHR. 2023; 135: S475-S476.
[Poster]
Web of Science
FullText
** Zweiker, D; Sieghartsleitner, R; Toth-Gayor, G; Stix, G; Vock, P; Schratter, A; Fiedler, L; Martinek, M; Steinwender, C; Binder, RK; Adukauskaite, A; Ablasser, K; Verheyen, N; Zirlik, A; Scherr, D
Size matters-Body size and acute device-implantation failure after left atrial appendage closure
WIEN KLIN WOCHENSCHR. 2023; 135: S410-S411.
[Poster]
Web of Science
** Brosolo, G; Catena, C; Da, Porto, A; Bulfone, L; Vacca, A; Verheyen, ND; Sechi, LA
Differences in Regulation of Cortisol Secretion Contribute to Left Ventricular Abnormalities in Patients With Essential Hypertension.
Hypertension. 2022; 79(7):1435-1444
Doi: 10.1161/HYPERTENSIONAHA.122.19472
Web of Science
PubMed
FullText
FullText_MUG
** Haudum, CW; Kolesnik, E; Colantonio, C; Mursic, I; Url-Michitsch, M; Tomaschitz, A; Glantschnig, T; Hutz, B; Lind, A; Schweighofer, N; Reiter, C; Ablasser, K; Wallner, M; Tripolt, NJ; Pieske-Kraigher, E; Madl, T; Springer, A; Seidel, G; Wedrich, A; Zirlik, A; Krahn, T; Stauber, R; Pieske, B; Pieber, TR; Verheyen, N; Obermayer-Pietsch, B; Schmidt, A
Cohort profile: 'Biomarkers of Personalised Medicine' (BioPersMed): a single-centre prospective observational cohort study in Graz/Austria to evaluate novel biomarkers in cardiovascular and metabolic diseases.
BMJ Open. 2022; 12(4):e058890
Doi: 10.1136/bmjopen-2021-058890
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Posch, F; Niedrist, T; Glantschnig, T; Firla, S; Moik, F; Kolesnik, E; Wallner, M; Verheyen, N; Jost, PJ; Zirlik, A; Pichler, M; Balic, M; Rainer, PP
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer.
Front Cardiovasc Med. 2022; 9: 933428
Doi: 10.3389/fcvm.2022.933428
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schweighofer, N; Colantonio, C; Haudum, CW; Hutz, B; Kolesnik, E; Mursic, I; Pilz, S; Schmidt, A; Stadlbauer, V; Zirlik, A; Pieber, TR; Verheyen, N; Obermayer-Pietsch, B
DXA-Derived Indices in the Characterisation of Sarcopenia.
Nutrients. 2021; 14(1):
Doi: 10.3390/nu14010186
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schweighofer, N; Haudum, CW; Trummer, O; Lind, A; Kolesnik, E; Mursic, I; Schmidt, A; Scherr, D; Zirlik, A; Pieber, TR; Verheyen, N; Obermayer-Pietsch, B
Dp-ucMGP as a Biomarker in Sarcopenia.
Nutrients. 2022; 14(24):
Doi: 10.3390/nu14245400
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Trummer, O; Foessl, I; Schweighofer, N; Arifi, E; Haudum, CW; Reintar, S; Pilz, S; Theiler-Schwetz, V; Trummer, C; Zirlik, A; Schmidt, A; Colantonio, C; Kolesnik, E; Verheyen, N; Pieber, TR; Obermayer-Pietsch, B
Expression Profiles of miR-22-5p and miR-142-3p Indicate Hashimoto's Disease and Are related to Thyroid Antibodies.
Genes (Basel). 2022; 13(2):
Doi: 10.3390/genes13020171
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Ungericht, M; Paar, L; Danninger, K; Schneiderbauer-Porod, S; Duca, F; Cherouny, B; Hoeller, V; Ablasser, K; Zach, D; Kolesnik, E; Kiblboeck, D; Frick, M; Bonderman, D; Dierneder, J; Ebner, C; Weber, T; Pölzl, G
Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis-A Retrospective Austrian Multicenter Study.
Biomedicines. 2022; 10(12):
Doi: 10.3390/biomedicines10123052
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** von, Lewinski, D; Herold, L; Stoffel, C; Pätzold, S; Fruhwald, F; Altmanninger-Sock, S; Kolesnik, E; Wallner, M; Rainer, P; Bugger, H; Verheyen, N; Rohrer, U; Manninger-Wünscher, M; Scherr, D; Renz, D; Yates, A; Zirlik, A; Toth, GG
PRospective REgistry of PAtients in REfractory cardiogenic shock-The PREPARE CardShock registry.
Catheter Cardiovasc Interv. 2022; 100(3):319-327
Doi: 10.1002/ccd.30327
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zweiker, D; Fiedler, L; Toth, GG; Strouhal, A; Delle-Karth, G; Stix, G; Gabriel, H; Binder, RK; Rammer, M; Pfeffer, M; Vock, P; Lileg, B; Steinwender, C; Sihorsch, K; Hintringer, F; Mueller, S; Barbieri, F; Martinek, M; Tkalec, W; Verheyen, N; Ablasser, K; Zirlik, A; Scherr, D
Not to Rush-Laboratory Parameters and Procedural Complications in Patients Undergoing Left Atrial Appendage Closure.
J Clin Med. 2022; 11(21):
Doi: 10.3390/jcm11216548
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Trummer, C; Theiler-Schwetz, V; Grübler, MR; Verheyen, ND; Odler, B; Karras, SN; Zittermann, A; März, W
Critical Appraisal of Large Vitamin D Randomized Controlled Trials.
Nutrients. 2022; 14(2):
Doi: 10.3390/nu14020303
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Grubler, M; Fielder, L; Tscharre, M; Haiden, A; Pfeffer, M; Hartmann, A; Thianich, F; Roithinger, FX; Verheyen, N; Trummer, C; Theiler-Schwetz, V; Pilz, S; Maerz, W
Markers of bone metabolism are associated in all-cause mortality in heart failure with reduced ejection fraction
EUR HEART J. 2022; 43: 844-844.
Web of Science
** Grubler, M; Zach, D; Holler, V; Seebacher, HA; Verheyen, N
A rare genetic cause of left ventricular hypertrophy and heart failure with preserved ejection fraction
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2):129-129.
[Poster]
Web of Science
** Hinterbuchner, K; Haudum, CW; Hutz, B; Kolesnik, E; Schmidt, A; Zirlik, A; Pieber, TR; Verheyen, N; Obermayer-Pietsch, B; Lohrmann, C; Grossschaedl, F; Colantonio, C
The Association of Cardiovascular Risk Factors and Depression of an adult Austrian Population
EUR J CARDIOVASC NUR. 2022; 21(SUPP_1):I73-I73.
Doi: 10.1093/eurjcn/zvac060.058
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Hochegger, P; Moser, L; Schnur, SSK; Pranevicius, R; Schmidt, A; Ablasser, K; Verheyen, N; Maier, R; Luha, O; Zirlik, A; Toth-Gayor, G
TEE-guided versus TEE-controlled PFO closure: Single Center Registry
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2):145-146.
[Oral Communication]
Web of Science
** Santner, V; Riepl, H; Posch, F; Wallner, M; Rainer, P; Ablasser, K; Kolesnik, E; von Lewinski, D; Kreuzer, P; Lueger, A; Petutschnigg, J; Pieske, B; Zirlik, A; Edelmann, F; Verheyen, N
Eligibility for HFpEF/HFmrEF outcome trials and mortality risk in a cohort of decompensated heart failure patients
WIEN KLIN WOCHENSCHR. Abstracts der Österreichische Kardiologische Gesellschaft Jahrestagung 2022. 2022; 134(SUPPL 2):100-100.-Österreichische Kardiologische Gesellschaft Jahrestagung 2022; MAI 25-28, 2022; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Santner, V; Riepl, H; Wallner, M; Rainer, P; Ablasser, K; Kolesnik, E; Von Lewinski, D; Kreuzer, P; Petutschnigg, J; Pieske, B; Zirlik, A; Edelmann, F; Verheyen, N
Eligibility for HFpEF and HFmrEF outcome trials and mortality risk in a cohort of decompensated heart failure patients. Do trial cohorts match with reality?
EUR J HEART FAIL. 2022; 24: 36-37.
[Oral Communication]
Web of Science
** Verheyen, N; Batzner, A; Zach, D; Gerull, B; Frantz, S; Maack, C; Stork, S; Seggewiss, H; Morbach, C
Quantification of systolic anterior motion of the mitral valve to identify left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2): 102-103.
[Poster]
Web of Science
** Verheyen, N; Batzner, A; Zach, D; Zirlik, A; Gerull, B; Stoerk, S; Maack, C; Seggewiss, H; Morbach, C
Quantification of systolic anterior motion of the mitral valve to predict left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy
EUR HEART J. 2022; 43: 158-158.
Web of Science
** Verheyen, N; Ungericht, M; Paar, L; Danninger, K; Schneiderbauer-Porod, S; Duca, F; Cherouney, B; Holler, V; Ablasser, K; Zach, D; Kiblbock, D; Frick, M; Bonderman, D; Dierneder, J; Ebner, C; Weber, T; Polzl, G
Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis-a retrospective Austrian multicenter study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2): 89-90.
[Poster]
Web of Science
** Verheyen, N; Ungericht, M; Paar, L; Danninger, K; Schneiderbauer-Porod, S; Duca, F; Hoeller, V; Ablasser, K; Kiblboeck, D; Frick, M; Bonderman, D; Dierneder, J; Ebner, C; Weber, T; Poelzl, G
Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis - a retrospective Austrian multicenter study
EUR HEART J. 2022; 43: 903-903.
Web of Science
** Zweiker, D; Sieghartsleitner, R; Fiedler, L; Toth-Gayor, G; Stix, G; Gabriel, H; Vock, P; Lileg, B; Strouhal, A; Delle-Karth, G; Pfeffer, M; Aichinger, J; Tkalec, W; Steinwender, C; Sihorsch, K; Binder, RK; Rammer, M; Barbieri, F; Mueller, S; Verheyen, N; Zirlik, A; Scherr, D
Left atrial appendage closure for stroke under oral anticoagulation
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2):189-190.
[Oral Communication]
Web of Science
** Alesutan, I; Luong, TTD; Schelski, N; Masyout, J; Hille, S; Schneider, MP; Graham, D; Zickler, D; Verheyen, N; Estepa, M; Pasch, A; Maerz, W; Tomaschitz, A; Pilz, S; Frey, N; Lang, F; Delles, C; Müller, OJ; Pieske, B; Eckardt, KU; Scherberich, J; Voelkl, J
Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signalling.
Cardiovasc Res. 2021; 117(3):930-941
Doi: 10.1093/cvr/cvaa081
Web of Science
PubMed
FullText
FullText_MUG
** Grübler, MR; Zittermann, A; Verheyen, ND; Trummer, C; Theiler-Schwetz, V; Keppel, MH; Malle, O; Richtig, G; Gängler, S; Bischoff-Ferrari, H; Scharnagl, H; Meinitzer, A; März, W; Tomaschitz, A; Pilz, S
Randomized trial of vitamin D versus placebo supplementation on markers of systemic inflammation in hypertensive patients.
Nutr Metab Cardiovasc Dis. 2021; 31(11):3202-3209
Doi: 10.1016/j.numecd.2021.07.028
Web of Science
PubMed
FullText
FullText_MUG
** Höller, V; Seebacher, H; Zach, D; Schwegel, N; Ablasser, K; Kolesnik, E; Gollmer, J; Waltl, G; Rainer, PP; Verheyen, S; Zirlik, A; Verheyen, N
Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy-The Graz Hypertrophic Cardiomyopathy Registry.
Genes (Basel). 2021; 12(10):
Doi: 10.3390/genes12101469
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jud, P; Verheyen, N; Dejaco, C; Haas, E; Szolar, D; Meinitzer, A; Duftner, C; Thonhofer, R; Gressenberger, P; Brodmann, M; Hafner, F
Prevalence and prognostic factors for aortic dilatation in giant cell arteritis - a longitudinal study.
Semin Arthritis Rheum. 2021; 51(4):911-918
Doi: 10.1016/j.semarthrit.2020.11.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Theiler-Schwetz, V; Trummer, C; Keppel, MH; Grübler, MR; Verheyen, N; Odler, B; Meinitzer, A; Voelkl, J; März, W
Associations of Serum Cortisol with Cardiovascular Risk and Mortality in Patients Referred to Coronary Angiography.
J Endocr Soc. 2021; 5(5):bvab017
Doi: 10.1210/jendso/bvab017
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N
News Severe Heart Failure in Patients with CHD - ischemic Cardiomyopathy or more?
J KARDIOL. 2021; 28(1-2): 42-44.
Web of Science
** Verheyen, N; Kafka, M; Schmidt, A; Toth, GG
Worsening Heart Failure After Transcatheter Aortic Valve Replacement: Unmasking the Left Ventricular Outflow Tract Obstruction.
JACC Cardiovasc Interv. 2021; 14(18): e253-e255.
Doi: 10.1016/j.jcin.2021.05.041
Web of Science
PubMed
FullText
FullText_MUG
** Zach, D; Ablasser, K; Kolesnik, E; Hoeller, V; Fruhwald, F; Prüller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Rainer, PP; Zirlik, A; Wölfler, A; Verheyen, N
Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio.
ESC Heart Fail. 2021; 8(4):3397-3402
Doi: 10.1002/ehf2.13381
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Grubler, M; Verheyen, ND; Meinitzer, A; Tascharre, M; Fiedler, L; Roithinger, FX; Maerz, W; Tomaschitz, A; Pilz, S
Association of female sexual hormones with QTc time in hypertensive subjects
EUR HEART J. 2021; 42: 639-639.
[Poster]
Web of Science
** Grubler, MR; Verheyen, ND; Meinitzer, A; Fiedler, L; Tscharre, M; Roithinger, FX; Tomaschitz, A; Pilz, S; Maerz, W
Digoxin treatment and long-term mortality depending on left ventricular ejection fraction and atrial fibrillation: a propensity score matched analysis
EUR HEART J. 2021; 42: 502-502.
[Poster]
Web of Science
** Holler, V; Zach, D; Kolesnik, E; Wallner, M; Fruhwald, F; Rainer, P; Zirlik, A; Verheyen, N
Proportions and temporal trends of diseases leading to a hypertrophic cardiomyopathy phenotype. a prospective single-center cohort study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 3):S98-S98.
[Onlinepräsentation]
Web of Science
** Horstmann, H; Michel, NA; Sheng, XS; Hansen, S; Lindau, A; Klymiuk, I; Marchini, T; Winkels, H; Verheyen, N; Gerhardt, T; Oswald, W; Conhert, T; Bode, C; Zirlik, A; Wolf, D
Integrative single cell RNA-sequencing descrambles a substantial divergence of adaptive immune cell identities and transcriptional programs in mouse and human atherosclerosis
EUR HEART J. 2021; 42: 3411-3411.
[Oral Communication]
Web of Science
** Riepl, H; Wallner, M; Kolesnik, E; Ablasser, K; Rainer, P; Fruhwald, F; Zirlik, A; Kreuzer, P; Lueger, A; Verheyen, N
Seasonal variation in decompensated heart failure in the emergency unit according to LVEF category-a retrospective analysis
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 3):S115-S117.
[Onlinepräsentation]
Web of Science
** Riepl, H; Wallner, M; Kolesnik, E; Ablasser, K; Rainer, P; Fruhwald, F; Zirlik, A; Kreuzer, P; Lueger, A; Verheyen, N
Seasonal variation in decompensated heart failure in the emergency unit according to LVEF category - a retrospective analysis
EUR J HEART FAIL. 2021; 23: 186-186.
[Poster]
Web of Science
** Schwegel, N; Kolesnik, E; Toth-Gayor, G; Zirlik, A; von Lewinski, D; Ablasser, K; Verheyen, N
Post-processing measurement of left ventricular ejection fraction compared to direct measurement in patients with heart failure with reduced ejection fraction
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 3):S110-S110.
[Poster]
Web of Science
** Schwegel, N; Kolesnik, E; Toth-Gayor, G; Zirlik, A; Von Lewinski, D; Ablasser, K; Verheyen, N
Post-processing measurement of left ventricular ejection fraction compared to direct measurement in patients with heart failure with reduced ejection fraction
EUR HEART J. 2021; 42: 789-789.
[Poster]
Web of Science
** Zweiker, D; Sieghartsleitner, R; Toth, G; Stix, G; Vock, P; Schratter, A; Fiedler, L; Aichinger, J; Steinwender, C; Binder, RK; Barbieri, F; Ablasser, K; Verheyen, N; Zirlik, A; Scherr, D
Low haemoglobin is associated with increased risk of complications in left atrial appendage closure patients
EUR HEART J. 2021; 42: 581-581.
[Poster]
Web of Science
** Zweiker, D; Sieghartsleitner, R; Toth, G; Stix, G; Vock, P; Schratter, A; Fiedler, L; Aichinger, J; Steinwender, C; Binder, RK; Barbieri, F; Ablasser, K; Verheyen, N; Zirlik, A; Scherr, D
Low haemoglobin is associated with increased risk of complications in left atrial appendage closure patients
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 3):S120-S121.
[Poster]
Web of Science
** Auer-Grumbach, M; Rettl, R; Ablasser, K; Agis, H; Beetz, C; Duca, F; Gattermeier, M; Glaser, F; Hacker, M; Kain, R; Kaufmann, B; Kovacs, GG; Lampl, C; Ljevakovic, N; Nagele, J; Pölzl, G; Quasthoff, S; Raimann, B; Rauschka, H; Reiter, C; Skrahina, V; Schuhfried, O; Sunder-Plassmann, R; Verheyen, ND; Wanschitz, J; Weber, T; Windhager, R; Wurm, R; Zimprich, F; Löscher, WN; Bonderman, D
Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots.
J Clin Med. 2020; 9(7):
Doi: 10.3390/jcm9072234
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bonderman, D; Pölzl, G; Ablasser, K; Agis, H; Aschauer, S; Auer-Grumbach, M; Binder, C; Dörler, J; Duca, F; Ebner, C; Hacker, M; Kain, R; Kammerlander, A; Koschutnik, M; Kroiss, AS; Mayr, A; Nitsche, C; Rainer, PP; Reiter-Malmqvist, S; Schneider, M; Schwarz, R; Verheyen, N; Weber, T; Zaruba, MM; Badr Eslam, R; Hülsmann, M; Mascherbauer, J
Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement.
Wien Klin Wochenschr. 2020; 132(23-24):742-761
Doi: 10.1007/s00508-020-01781-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Grübler, MR; Delgado, G; Kleber, M; Hartaigh, BÓ; de, Boer, RA; Verheyen, N; Keppel, M; Schmid, J; Siontis, GC; Räber, L; Pieske, B; Pilz, S; Tomaschitz, A; März, W
Effect of Galectin 3 on Aldosterone-Associated Risk of Cardiovascular Mortality in Patients Undergoing Coronary Angiography.
Am J Cardiol. 2020; 127:9-15
Doi: 10.1016/j.amjcard.2020.04.017
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Steinberger, E; Pilz, S; Trummer, C; Theiler-Schwetz, V; Reichhartinger, M; Benninger, T; Pandis, M; Malle, O; Keppel, MH; Verheyen, N; Grübler, MR; Voelkl, J; Meinitzer, A; März, W
Associations of Thyroid Hormones and Resting Heart Rate in Patients Referred to Coronary Angiography.
Horm Metab Res. 2020; 52(12):850-855
Doi: 10.1055/a-1232-7292
Web of Science
PubMed
FullText
FullText_MUG
** Tripolt, NJ; Kolesnik, E; Pferschy, PN; Verheyen, N; Ablasser, K; Sailer, S; Alber, H; Berger, R; Kaulfersch, C; Leitner, K; Lichtenauer, M; Mader, A; Moertl, D; Oulhaj, A; Reiter, C; Rieder, T; Saely, CH; Siller-Matula, J; Weidinger, F; Zechner, PM; von Lewinski, D; Sourij, H; EMMY study group
Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial.
Am Heart J. 2020; 221:39-47
Doi: 10.1016/j.ahj.2019.12.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zweiker, D; Sieghartsleitner, R; Fiedler, L; Toth, GG; Luha, O; Stix, G; Gabriel, H; Vock, P; Lileg, B; Strouhal, A; Delle-Karth, G; Pfeffer, M; Aichinger, J; Tkalec, W; Steinwender, C; Sihorsch, K; Binder, RK; Rammer, M; Barbieri, F; Mueller, S; Verheyen, N; Ablasser, K; Zirlik, A; Scherr, D
Indications and Outcome in Patients Undergoing Left Atrial Appendage Closure-The Austrian LAAC Registry.
J Clin Med. 2020; 9(10):
Doi: 10.3390/jcm9103274
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hoffmann, M; Jeitziner, MM; Riedl, R; Eller, P; Amrein, K, , ICU-Families, Study, Group
Psychological symptoms in relatives of critically ill patients (ICU families): a prospective multicenter study.
Intensive Care Med. 2020; 46(5):1060-1062
Doi: 10.1007/s00134-020-05997-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jud, P; Verheyen, N; Aliabadi, A
Stork leg sign in acute pericarditis.
Pol Arch Intern Med. 2020; 130(7-8):683-684
Doi: 10.20452/pamw.15412
Web of Science
PubMed
FullText
FullText_MUG
** Steinberger, E; Pilz, S; Trummer, C; Theiler-Schwetz, V; Reichhartinger, M; Benninger, T; Pandis, M; Malle, O; Keppel, MH; Verheyen, N; Grübler, MR; Voelkl, J; Meinitzer, A; März, W
Correction: Associations of Thyroid Hormones and Resting Heart Rate in Patients Referred to Coronary Angiography.
Horm Metab Res. 2020; 52(12): e5
Doi: 10.1055/a-1260-4769
Web of Science
PubMed
FullText
FullText_MUG
** Gollmer, J; Verheyen, N; Ablasser, K; Zirngast, B; Marte, W; Buschmann, E; Machler, H; Zirlik, A; Schmidt, A
Procedural Results and Characteristics of Patients after interventional Tricuspid Calve Therapy with the MitraClip Device in severe Tricuspid Valve Regurgitation.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):84-84.-51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Habenicht, V; Ablasser, K; Kolesnik, E; Schmid, J; Kattnig, L; Bencic, D; Gangl, M; Scherr, D; Zirlik, A; Fruhwald, F; von Lewinski, D; Verheyen, N
Comparison of three different methods to measure heart rate in patients with chronic heart failure.
WIEN KLIN WOCHENSCHR. 2020; 132: S207-S208.
[Poster]
Web of Science
FullText
** Hoheneder, T; Ablasser, K; Zach, D; Kolesnik, E; Binder, J; Scherr, D; Fruhwald, F; Zirlik, A; von Lewinski, D; Verheyen, N
Echocardiographic right ventricular function assessment in patients with chronic heart failure-comparison between TAPSE and myocardial deformation analysis.
WIEN KLIN WOCHENSCHR. 2020; 132: S200-S201.
[Poster]
Web of Science
FullText
** Treiber, G; Verheyen, N; Verheyen, S; Mader, JK; Sourij, H
"Atypical" Diabetes - There´s more than Type 1 and Type 2-A Case Report.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):69-69.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
Web of Science
FullText
** Tripolt, N; Pferschy, P; Kolesnik, E; Verheyen, N; Ablasser, K; Sailer, S; Breitegger, J; Alber, H; Berger, R; Leitner, K; Lichtenauer, M; Mortl, D; Oulhaj, A; Reiter, C; Rieder, T; Saly, C; Siller-Matula, J; Weidinger, F; Zechner, P; Von Lewinski, D; Sourij, H
Impact of Empagliflozin on cardiac Function and Heart Failure Biomarkers in Patients with acute Myocardial Infarction - EMMY-Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S345-S345.
[Poster]
Web of Science
** Verheyen, N; Schmid, J; Kolesnik, E; Bencic, D; Kattnig, L; Scherr, D; Manninger, M; Fruhwald, F; Obermayer-Pietsch, B; Fahrleitner-Pammer, A; Zirlik, A; von Lewinski, D; Ablasser, K
Prevalence and determinants of bone disease in patients with chronic heart failure-a prospective cohort study.
WIEN KLIN WOCHENSCHR. 2020; 132: S234-S235.
[Poster]
Web of Science
FullText
** Zach, D; Ablasser, K; Kolesnik, E; Fruhwald, F; Pruller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Zirlik, A; Wolfler, A; Verheyen, N
Massive cardiac AL amyloidosis in the absence of monoclonal gammopathy.
WIEN KLIN WOCHENSCHR. 2020; 132: S237-S237.
[Poster]
Web of Science
FullText
** Zach, D; Ablasser, K; Kolesnik, E; Fruhwald, F; Pruller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Zirlik, A; Wolfler, A; Verheyen, N
The exceptional Case of massive cardiac AL-Amyloidosis with missing monoclonal Gammopathy.
WIEN KLIN WOCHENSCHR. Abstracts 51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):73-73.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Amrein, K; Parekh, D; Westphal, S; Preiser, JC; Berghold, A; Riedl, R; Eller, P; Schellongowski, P; Thickett, D; Meybohm, P; VITDALIZE Collaboration Group
Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study).
BMJ Open. 2019; 9(11):e031083-e031083
Doi: 10.1136/bmjopen-2019-031083
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Belyavskiy, E; Morris, DA; Url-Michitsch, M; Verheyen, N; Meinitzer, A; Radhakrishnan, AK; Kropf, M; Frydas, A; Ovchinnikov, AG; Schmidt, A; Tadic, M; Genger, M; Lindhorst, R; Bobenko, A; Tschöpe, C; Edelmann, F; Pieske-Kraigher, E; Pieske, B
Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study.
ESC Heart Fail. 2019; 6(1):146-153
Doi: 10.1002/ehf2.12375
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bobenko, A; Schoenrath, F; Knierim, JH; Friede, T; Verheyen, N; Mehra, MR; Haykowsky, M; Herrmann-Lingen, C; Duvinage, A; Pieske-Kraigher, E; Halle, M; Falk, V; Pieske, B; Edelmann, F
Exercise training in patients with a left ventricular assist device (Ex-VAD): rationale and design of a multicentre, prospective, assessor-blinded, randomized, controlled trial.
EUR J HEART FAIL. 2019; 21(9): 1152-1159.
Doi: 10.1002/ejhf.1431
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Francic, V; Keppel, M; Schwetz, V; Trummer, C; Pandis, M; Borzan, V; Grübler, MR; Verheyen, ND; Kleber, ME; Delgado, G; Moissl, AP; Dieplinger, B; März, W; Tomaschitz, A; Pilz, S; Obermayer-Pietsch, B
Are soluble ST2 levels influenced by vitamin D and/or the seasons?
ENDOCR CONNECT. 2019; 8(6): 691-700.
Doi: 10.1530/EC-19-0090
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Francic, V; Ursem, SR; Dirks, NF; Keppel, MH; Theiler-Schwetz, V; Trummer, C; Pandis, M; Borzan, V; Grübler, MR; Verheyen, ND; März, W; Tomaschitz, A; Pilz, S; Heijboer, AC; Obermayer-Pietsch, B
The Effect of Vitamin D Supplementation on its Metabolism and the Vitamin D Metabolite Ratio.
Nutrients. 2019; 11(10):
Doi: 10.3390/nu11102539
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Keppel, MH; Piecha, G; März, W; Cadamuro, J; Auer, S; Felder, TK; Mrazek, C; Oberkofler, H; Trummer, C; Grübler, MR; Schwetz, V; Verheyen, N; Pandis, M; Borzan, V; Haschke-Becher, E; Tomaschitz, A; Pilz, S
The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension.
PLoS One. 2019; 14(2):e0212973
Doi: 10.1371/journal.pone.0212973
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kolesnik, E; Krainer, T; Wallner, M; Djalinac, N; Verheyen, N; Ablasser, K; Eaton, DM; Rainer, PP; Pelzmann, B; von Lewinski, D
Myocardial GLP-1 Receptor Activation in the Presence of Glucose: Strong Partners
INT J PEPT RES THER. 2019; 25(2): 605-612.
Doi: 10.1007/s10989-018-9706-9
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Pilz, S; Keppel, MH; Trummer, C; Theiler-Schwetz, V; Pandis, M; Borzan, V; Pittrof, M; Obermayer-Pietsch, B; Grübler, MR; Verheyen, N; Stepan, V; Meinitzer, A; Voelkl, J; März, W; Tomaschitz, A
Diagnostic Accuracy of the Aldosterone-to-Active Renin Ratio for Detecting Primary Aldosteronism.
J Endocr Soc. 2019; 3(9):1748-1758
Doi: 10.1210/js.2019-00145
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sacherer, M; Kolesnik, E; von, Lewinski, F; Verheyen, N; Brandner, K; Wallner, M; Eaton, DM; Luha, O; Zweiker, R; von, Lewinski, D
Thermic sealing in femoral catheterization: First experience with the Secure Device.
Cardiol J. 2019; 26(3):233-240
Doi: 10.5603/CJ.a2018.0035
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stekovic, S; Hofer, SJ; Tripolt, N; Aon, MA; Royer, P; Pein, L; Stadler, JT; Pendl, T; Prietl, B; Url, J; Schroeder, S; Tadic, J; Eisenberg, T; Magnes, C; Stumpe, M; Zuegner, E; Bordag, N; Riedl, R; Schmidt, A; Kolesnik, E; Verheyen, N; Springer, A; Madl, T; Sinner, F; de Cabo, R; Kroemer, G; Obermayer-Pietsch, B; Dengjel, J; Sourij, H; Pieber, TR; Madeo, F
Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans.
Cell Metab. 2019; 30(3):462-476
Doi: 10.1016/j.cmet.2019.07.016
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Trummer, C; Schwetz, V; Pandis, M; Grübler, MR; Verheyen, N; Gaksch, M; Zittermann, A; März, W; Aberer, F; Steinkellner, J; Friedl, C; Brandenburg, V; Voelkl, J; Alesutan, I; Obermayer-Pietsch, B; Pieber, TR; Tomaschitz, A; Pilz, S
Effects of vitamin D supplementation on FGF23: a randomized-controlled trial.
Eur J Nutr. 2019; 58(2):697-703
Doi: 10.1007/s00394-018-1672-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ursem, S; Francic, V; Keppel, M; Schwetz, V; Trummer, C; Pandis, M; Aberer, F; Grübler, MR; Verheyen, ND; März, W; Tomaschitz, A; Pilz, S; Obermayer-Pietsch, B; Heijboer, AC
The effect of vitamin D supplementation on plasma non-oxidised PTH in a randomised clinical trial.
Endocr Connect. 2019; 8(5):518-527
Doi: 10.1530/EC-19-0097
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ablasser, K; Verheyen, N; Glantschnig, T; Agnetti, G; Rainer, PP
Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.
Curr Med Chem. 2019; 26(16):2865-2878
Doi: 10.2174/0929867325666180104153338
Web of Science
PubMed
FullText
FullText_MUG
** Ablasser, K; Von Lewinski, D; Kolesnik, E; Gangl, M; Kattnig, L; Habenicht, V; Manninger, M; Scherr, D; Schmid, J; Fruhwald, F; Zirlik, A; Verheyen, N
Comparison of global longitudinal strain and ejection fraction in correlation to NT-proBNP in ischemic and non-ischemic heart failure
EUR HEART J. 2019; 40: 1572-1572.-ESC Congress / World Congress of Cardiology; AUG 31-SEP 04, 2019; Paris, FRANCE.
[Poster]
Web of Science
** Ablasser, ,K; von Lewinski, D; Kolesnik, E; Gangl, M; Kattnig, L; Habenicht, V; Manninger-Wünscher, M; Scherr, D; Schmidt, J; Fruhwald, F; Zirlik, A; Verheyen, N
Comparison of global longitudinal strain and ejection fraction in correlation to NT-proBNP in ischemic and non-ischemic heart failure
Wiener Klinische Wochenschrift. 2019; 131(Suppl):348-348.-Jahrestagung der Österreichischen Kardiologischen Gesellschaft; MAY 29 - JUNE 1, 2019; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Bencic, D; Schmid, J; Fuchsjager, M; Fahrleitner-Pammer, A; Obermayer-Pietsch, B; Pieber, T; Kolesnik, E; Zirlik, A; Fruhwald, F; von Lewinski, D; Ablasser, K; Verheyen, N; Tomaschitz, A; Scherr, D
Association between plasma sodium and bone disease in patients with chronic heart failure: a prospective cohort study
J BONE MINER RES. 2019; 34: 357-357.-Annual Meeting of the American-Society-for-Bone-and Mineral Research; SEP 20-23, 2019; Orlando, FL.
[Poster]
Web of Science
** Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, ND; Schmid, J; Müllner, C; Richtig, G; Scharnagl, H; Trummer, C; Schwetz, V; Meinitzer, A; Pieske, B; März, W; Tomaschitz, A; Pilz, S
Effects of Vitamin D3 on asymmetric- and symmetric dimethylarginine in arterial hypertension.
J Steroid Biochem Mol Biol. 2018; 175:157-163
Doi: 10.1016/j.jsbmb.2016.12.014
Web of Science
PubMed
FullText
FullText_MUG
** Jud, P; Hafner, F; Verheyen, N; Gary, T; Meinitzer, A; Brodmann, M; Seinost, G; Hackl, G
Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease.
Heart Vessels. 2018; 33(12): 1453-1462.
Doi: 10.1007/s00380-018-1210-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jud, P; Hafner, F; Verheyen, N; Meinitzer, A; Gary, T; Brodmann, M; Seinost, G; Hackl, G
Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease.
Sci Rep. 2018; 8(1):14197-14197
Doi: 10.1038/s41598-018-32607-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Trummer, C; Verheyen, N; Schwetz, V; Pandis, M; Aberer, F; Grübler, MR; Meinitzer, A; Bachmann, A; Voelkl, J; Alesutan, I; Catena, C; Sechi, LA; März, W; Obermayer-Pietsch, B; Tomaschitz, A
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.
Horm Metab Res. 2018; 50(5):375-382
Doi: 10.1055/a-0604-3249
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwetz, V; Scharnagl, H; Trummer, C; Stojakovic, T; Pandis, M; Grübler, MR; Verheyen, N; Gaksch, M; Zittermann, A; Aberer, F; Lerchbaum, E; Obermayer-Pietsch, B; Pieber, TR; März, W; Tomaschitz, A; Pilz, S
Vitamin D supplementation and lipoprotein metabolism: A randomized controlled trial.
J Clin Lipidol. 2018; 12(3):588-596.e4
Doi: 10.1016/j.jacl.2018.03.079
Web of Science
PubMed
FullText
FullText_MUG
** Tripolt, NJ; Stekovic, S; Aberer, F; Url, J; Pferschy, PN; Schröder, S; Verheyen, N; Schmidt, A; Kolesnik, E; Narath, SH; Riedl, R; Obermayer-Pietsch, B; Pieber, TR; Madeo, F; Sourij, H
Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial.
Adv Ther. 2018; 35(8):1265-1283
Doi: 10.1007/s12325-018-0746-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Voelkl, J; Tuffaha, R; Luong, TTD; Zickler, D; Masyout, J; Feger, M; Verheyen, N; Blaschke, F; Kuro-O, M; Tomaschitz, A; Pilz, S; Pasch, A; Eckardt, KU; Scherberich, JE; Lang, F; Pieske, B; Alesutan, I
Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB.
J Am Soc Nephrol. 2018; 29(6): 1636-1648.
Doi: 10.1681/ASN.2017050492
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; März, W; Cashman, KD; Kiely, ME; Whiting, SJ; Holick, MF; Grant, WB; Pludowski, P; Hiligsmann, M; Trummer, C; Schwetz, V; Lerchbaum, E; Pandis, M; Tomaschitz, A; Grübler, MR; Gaksch, M; Verheyen, N; Hollis, BW; Rejnmark, L; Karras, SN; Hahn, A; Bischoff-Ferrari, HA; Reichrath, J; Jorde, R; Elmadfa, I; Vieth, R; Scragg, R; Calvo, MS; van, Schoor, NM; Bouillon, R; Lips, P; Itkonen, ST; Martineau, AR; Lamberg-Allardt, C; Zittermann, A
Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper.
Front Endocrinol (Lausanne). 2018; 9:373
Doi: 10.3389/fendo.2018.00373
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Trummer, C; Pandis, M; Schwetz, V; Aberer, F; Grübler, M; Verheyen, N; Tomaschitz, A; März, W
Vitamin D: Current Guidelines and Future Outlook.
Anticancer Res. 2018; 38(2):1145-1151
Doi: 10.21873/anticanres.12333
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Grübler, MR; Catena, C; Fahrleitner-Pammer, A; van Ballegooijen, AJ
The Bone-Cardiovascular Axis: Mechanisms and Clinical Relevance.
Int J Endocrinol. 2018; 2018(5):9689106-9689106
Doi: 10.1155/2018/9689106
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jud, P; Verheyen, N
Lancisi sign in a 69-year-old man with severe tricuspid regurgitation.
CMAJ. 2018; 190(1):E17-E17
Doi: 10.1503/cmaj.171297
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jud, P; Verheyen, N; Fruhwald, F
Multiple Chronic Gouty Tophi.
Dtsch Arztebl Int. 2018; 115(3): 30-30.
Doi: 10.3238/arztebl.2018.0030
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ablasser, K; Zechner, P; Muster, A; Taucher, V; Kolesnik, E; Verheyen, N; Toth, G; Schuchlenz, H; Von Lewinski, D
Effects of snowfall and temperature on the incidence of over 18000 acute coronary syndrome cases
EUR HEART J. 2018; 39: 1353-1353.-European-Society-of-Cardiology Congress; AUG 25-29, 2018; Munich, GERMANY.
[Poster]
Web of Science
** Ablasser, KK; Gangl, M; Kolesnik, E; Kattnig, L; Manninger, M; Scherr, D; Von Lewinski, D; Fruhwald, F; Verheyen, N
Correlation of strain and strain-rate imaging and left ventricular function in ischemic and non-ischemic chronic heart failure patients
EUR J HEART FAIL. 2018; 20: 163-163.
[Poster]
Web of Science
** Belyavskiy, E; Morris, DA; Url-Michitsch, M; Verheyen, N; Krishnan, AKR; Frydas, A; Huang, F; Kropf, M; Lindhorst, R; Bobenko, A; Tadic, M; Tschoepe, C; Edelmann, F; Pieske-Kraigher, E; Pieske, B
Potential usefulness of diastolic stress-test echocardiography in patients with suspicion of heart failure with preserved ejection fraction - a pilot study
EUR J HEART FAIL. 2018; 20: 231-232.
[Poster]
Web of Science
** Gangl, M; Kolesnik, E; Kattnig, L; Habenicht, V; Manninger, M; Schmid, J; Scherr, D; Fruhwald, F; Von Lewinski, D; Verheyen, N; Ablasser, KK
Correlation of global longitudinal strain and NT-proBNP in ischemic and non-ischemic chronic heart failure patients
EUR J HEART FAIL. 2018; 20: 163-164.
[Poster]
Web of Science
** Kattnig, L; Habenicht, V; Gangi, M; Kolesnik, E; Schmid, J; Manninger, M; Brussee, H; Pilz, S; Tomaschitz, A; Obermayer-Pietsch, B; Scherr, D; Fruhwald, F; Von Lewinski, D; Ablasser, K; Verheyen, N
Relationship between parathyroid hormone and cardiac function and congestion in chronic heart failure: a prospective cohort study
EUR J HEART FAIL. . 2018; 20: 410-410.-ESC Heart Failure; Wien.
[Poster]
Web of Science
** Kattnig, L; Habenicht, V; Gangl, M; Kolesnik, E; Schmid, J; Manninger, M; Tomaschitz, A; Obermayer-Pietsch, B; Scherr, D; Fruhwald, F; von Lewinski, D; Ablasser, K; Verheyen, N
Relationship between parathyroid hormone and cardiac function and congestion in chronic heart failure: a prospective cohort study
WIEN KLIN WOCHENSCHR. 2018; 130: 52-52.
[Poster]
Web of Science
** Sieghartsleitner, R; Toth-Gayor, G; Zweiker, D; Manninger, M; Odeneg, T; Mastnak, B; Ablasser, K; Verheyen, N; Stoschitzky, G; Maier, R; Luha, O; Brussee, H; Scherr, D
Is there an impact of left atrial appendage morphology on the incidence of peri device leaks?
WIEN KLIN WOCHENSCHR. 2018; 130: 118-118.
[Poster]
Web of Science
** Sternad, J; Manninger, M; Scherr, D; Zweiker, D; Kolesnik, E; Obermayer-Pietsch, B; Pieber, T; von Lewinski, D; Verheyen, N; Ablasser, K
Level of Vitamin D predicts occurrence of atrial high rate episodes in patients with chronic heart failure
WIEN KLIN WOCHENSCHR. 2018; 130: 55-56.
[Poster]
Web of Science
** Verheyen, N; Stoschitzky, G; Binder, J; Ablasser, K; Knez, I; Dapunt, O; Gamillscheg, A; Maier, R
Unexpected blood flow from pulmonary veins during cardiopulmonary bypass for mitral valve surgery in a 62-year-old woman
WIEN KLIN WOCHENSCHR. 2018; 130: 49-51.
[Poster]
Web of Science
** Verheyen, NN; Stoschitzky, G; Binder, J; Ablasser, K; Dapunt, O; Knez, I; Gamillscheg, A; Maier, R
Unexpected blood flow from pulmonary veins during cardiopulmonary bypass for mitral valve surgery in a 62-year-old woman
EUR J HEART FAIL. 2018; 20: 347-347.
[Poster]
Web of Science
** Glantschnig, T; Ablasser, K; Verheyen, N; von Lewinski, D; Rainer, PP
What may happen when you are expecting - a case of peripartum
cardiomyopathy
Eur J Heart Failure. 2018; 20(S1):358-358.-Heart Failure Association ESC; MAY 26-29, 2018; Vienna, AUSTRIA.
[Poster]
Web of Science
** Catena, C; Colussi, G; Brosolo, G; Verheyen, N; Novello, M; Bertin, N; Cavarape, A; Sechi, LA
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis.
Kidney Blood Press Res. 2017; 42(5):774-783
Doi: 10.1159/000484299
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwetz, V; Trummer, C; Pandis, M; Grübler, MR; Verheyen, N; Gaksch, M; Zittermann, A; März, W; Aberer, F; Lang, A; Treiber, G; Friedl, C; Obermayer-Pietsch, B; Pieber, TR; Tomaschitz, A; Pilz, S
Effects of Vitamin D Supplementation on Bone Turnover Markers: A Randomized Controlled Trial.
Nutrients. 2017; 9(5):
Doi: 10.3390/nu9050432
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Trummer, C; Schwetz, V; Pandis, M; Grübler, MR; Verheyen, N; Gaksch, M; Zittermann, A; März, W; Aberer, F; Lang, A; Friedl, C; Tomaschitz, A; Obermayer-Pietsch, B; Pieber, TR; Pilz, S; Treiber, G
Effects of Vitamin D Supplementation on IGF-1 and Calcitriol: A Randomized-Controlled Trial.
Nutrients. 2017; 9(6):
Doi: 10.3390/nu9060623
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Fahrleitner-Pammer, A; Belyavskiy, E; Gruebler, MR; Dimai, HP; Amrein, K; Ablasser, K; Martensen, J; Catena, C; Pieske-Kraigher, E; Colantonio, C; Voelkl, J; Lang, F; Alesutan, I; Meinitzer, A; März, W; Brussee, H; Pieske, B; Pilz, S; Tomaschitz, A
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.
PLoS One. 2017; 12(4):e0173799-e0173799
Doi: 10.1371/journal.pone.0173799
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Grübler, MR; Meinitzer, A; Trummer, C; Schwetz, V; Amrein, K; Dimai, HP; März, W; Catena, C; von Lewinski, D; Voelkl, J; Alesutan, I; Fahrleitner-Pammer, A; Brussee, H; Pilz, S; Tomaschitz, A
Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.
Bone. 2017; 105(5):212-217
Doi: 10.1016/j.bone.2017.08.030
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Meinitzer, A; Grübler, MR; Ablasser, K; Kolesnik, E; Fahrleitner-Pammer, A; Belyavskiy, E; Trummer, C; Schwetz, V; Pieske-Kraigher, E; Voelkl, J; Alesutan, I; Catena, C; Sechi, LA; Brussee, H; Lewinski, DV; März, W; Pieske, B; Pilz, S; Tomaschitz, A
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.
Clin Chem Lab Med. 2017; 55(7):1034-1042
Doi: 10.1515/cclm-2016-1159
Web of Science
PubMed
FullText
FullText_MUG
** Wetzel, J; Pilz, S; Grübler, MR; Fahrleitner-Pammer, A; Dimai, HP; von Lewinski, D; Kolesnik, E; Perl, S; Trummer, C; Schwetz, V; Meinitzer, A; Belyavskiy, E; Völkl, J; Catena, C; Brandenburg, V; März, W; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, ND
Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.
J Clin Hypertens (Greenwich). 2017; 19(11):1173-1180
Doi: 10.1111/jch.13064
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Grübler, MR; März, W; Pilz, S; Grammer, TB; Trummer, C; Müllner, C; Schwetz, V; Pandis, M; Verheyen, N; Tomaschitz, A; Fiordelisi, A; Laudisio, D; Cipolletta, E; Iaccarino, G
Vitamin-D concentrations, cardiovascular risk and events - a review of epidemiological evidence.
Rev Endocr Metab Disord. 2017; 18(2):259-272
Doi: 10.1007/s11154-017-9417-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** van Ballegooijen, AJ; Pilz, S; Tomaschitz, A; Grübler, MR; Verheyen, N
The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review.
Int J Endocrinol. 2017; 2017(1):7454376-7454376
Doi: 10.1155/2017/7454376
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Habenicht F; Kolesnik E; Schmid J; Brandner K; Tomaschitz A; Pilz S;
Fruhwald F; Von Lewinski D; Ablasser K; Verheyen N
Comparison of office heart rate and mean 24-hours ambulatory heart rate in chronic heart failure patients.
European Journal of Heart Failure. 2017; 19(Suppl ):54-54.-Heart Failure 2017; APR 27 - MAY 2, 2017; Paris, FRANCE.
[Poster]
Web of Science
** Voelki, J; Tuffaha, R; Verheyen, N; Feger, M; Kuro-O, M; Tomaschitz, A; Pilz, S; Pieske, B; Lang, F; Alesutan, I
Zinc supplementation inhibits the phosphate-induced vascular smooth muscle cell calcification via A20-mediated suppression of NF-kB
ACTA PHYSIOL. 2017; 219: 64-64.
[Poster]
Web of Science
** Catena, C; Colussi, G; Novello, M; Verheyen, ND; Bertin, N; Pilz, S; Tomaschitz, A; Sechi, LA
Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study.
Hypertension. 2016; 68(1):204-212
Doi: 10.1161/HYPERTENSIONAHA.116.07615
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Catena, C; Colussi, G; Verheyen, ND; Novello, M; Fagotto, V; Soardo, G; Sechi, LA
Moderate Alcohol Consumption Is Associated With Left Ventricular Diastolic Dysfunction in Nonalcoholic Hypertensive Patients.
Hypertension. 2016; 68(5):1208-1216
Doi: 10.1161/HYPERTENSIONAHA.116.08145
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Catena, C; Verheyen, ND; Url-Michitsch, M; Kraigher-Krainer, E; Colussi, G; Pilz, S; Tomaschitz, A; Pieske, B; Sechi, LA
Association of Post-Saline Load Plasma Aldosterone Levels With Left Ventricular Hypertrophy in Primary Hypertension.
Am J Hypertens. 2016; 29(3):303-310
Doi: 10.1093/ajh/hpv104
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ernst, JB; Tomaschitz, A; Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, N; März, W; Pilz, S; Zittermann, A
Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial.
Int J Endocrinol. 2016; 2016:6836402
Doi: 10.1155/2016/6836402
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, N; Schmid, J; Ó, Hartaigh, B; Richtig, G; Scharnagl, H; Meinitzer, A; Fahrleitner-Pammer, A; März, W; Tomaschitz, A; Pilz, S
Effects of vitamin D supplementation on glycated haemoglobin and fasting glucose levels in hypertensive patients: a randomized controlled trial.
Diabetes Obes Metab. 2016; 18(10):1006-12
Doi: 10.1111/dom.12709
Web of Science
PubMed
FullText
FullText_MUG
** Grübler, MR; Gaksch, M; Kienreich, K; Verheyen, N; Schmid, J; Ó, Hartaigh, BW; Richtig, G; Scharnagl, H; Meinitzer, A; Pieske, B; Fahrleitner-Pammer, A; März, W; Tomaschitz, A; Pilz, S
Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.
J Clin Hypertens (Greenwich). 2016; 18(7):608-13
Doi: 10.1111/jch.12825
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Grübler, MR; Kienreich, K; Gaksch, M; Verheyen, N; Hartaigh, BÓ; Fahrleitner-Pammer, A; März, W; Schmid, J; Oberreither, EM; Wetzel, J; Catena, C; Sechi, LA; Pieske, B; Tomaschitz, A; Pilz, S
Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive Patients.
Medicine (Baltimore). 2016; 95(8):e2794
Doi: 10.1097/MD.0000000000002794
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schmid, J; Kaufmann, R; Grübler, MR; Verheyen, N; Weidemann, F; Binder, JS
Strain Analysis by Tissue Doppler Imaging: Comparison of Conventional Manual Measurement with a Semiautomated Approach.
Echocardiography. 2016; 33(3):372-378
Doi: 10.1111/echo.13100
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Rus-Machan, J; Dimai, HP; Seiwald, G; Brussee, H; Weinrauch, V; Verheyen, N; Fahrleitner-Pammer, A; Pilz, S
The Bone-Cardiovascular Axis: A Systematic Review of Prospective Studies
J MINERAL. 2016; 23(3): 86-93.
[OPEN ACCESS]
Web of Science
** Tomaschitz, A; Verheyen, N; Meinitzer, A; Pieske, B; Belyavskiy, E; Brussee, H; Haas, J; März, W; Pieske-Kraigher, E; Verheyen, S; Ofner-Ziegenfuss, L; Hartaigh, BÓ; Schwetz, V; Aberer, F; Grübler, M; Lang, F; Alesutan, I; Voelkl, J; Gaksch, M; Horina, JH; Dimai, HP; Rus-Machan, J; Stiegler, C; Ritz, E; Fahrleitner-Pammer, A; Pilz, S
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
J Hypertens. 2016; 34(7):1347-56
Doi: 10.1097/HJH.0000000000000927
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Fahrleitner-Pammer, A; Pieske, B; Meinitzer, A; Belyavskiy, E; Wetzel, J; Gaksch, M; Grübler, MR; Catena, C; Sechi, LA; Van, Ballegooijen, AJ; Brandenburg, VM; Scharnagl, H; Perl, S; Brussee, H; März, W; Pilz, S; Tomaschitz, A
Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
J Hypertens. 2016; 34(9):1778-86
Doi: 10.1097/HJH.0000000000001004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, ND; Kienreich, K; Gaksch, M; van, Ballegooijen, AJ; Grübler, MR; Hartaigh, BÓ; Schmid, J; Fahrleitner-Pammer, A; Kraigher-Krainer, E; Colantonio, C; Belyavskiy, E; Treiber, G; Catena, C; Brussee, H; Pieske, B; März, W; Tomaschitz, A; Pilz, S
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study.
J Clin Hypertens (Greenwich). 2016; 18(6):543-50
Doi: 10.1111/jch.12710
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Grübler, M; Gaksch, M; Schwetz, V; Trummer, C; Hartaigh, BÓ; Verheyen, N; Tomaschitz, A; März, W
Vitamin D and Mortality.
Anticancer Res. 2016; 36(3):1379-87
Web of Science
PubMed
** Pilz, S; Verheyen, N; Grübler, MR; Tomaschitz, A; März, W
Vitamin D and cardiovascular disease prevention.
Nat Rev Cardiol. 2016; 13(7):404-417
Doi: 10.1038/nrcardio.2016.73
Web of Science
PubMed
FullText
FullText_MUG
** Trummer, C; Pandis, M; Verheyen, N; Grübler, MR; Gaksch, M; Obermayer-Pietsch, B; Tomaschitz, A; Pieber, TR; Pilz, S; Schwetz, V
Beneficial Effects of UV-Radiation: Vitamin D and beyond.
Int J Environ Res Public Health. 2016; 13(10):
Doi: 10.3390/ijerph13101028
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Colantonio, C; Url-Michitsch, M; Verheyen, N; Kolesnik, E; Kresoja, K; Schutzenhofer, K; Pieske, B; Brussee, H; Schmidt, A
The Graz Heart Study - Partial Evaluation of the echocardiographic Basic Data Set
WIEN KLIN WOCHENSCHR. 2016; 128: S307-S307.
[Poster]
Web of Science
** Colantonio, C; Url-Michitsch, M; Verheyen, N; Kresoja, K; Kolesnik, E; Schutzenhofer, K; Pieske, B; Brussee, H; Schmidt, A;
The Graz Heart Study.
WIEN KLIN WOCHENSCHR. 2016; 128: S306-S307.
[Poster]
Web of Science
** de Jonge, F; Kolesnik, E; Verheyen, N; Seidel, G; Singer, C; Tripolt, N; Url-Michitsch, M; Colantonio, C; Pieske, B; Schmidt, A
Retinal vessel caliber, pulse wave velocity and intima-media thickness of the carotic artery as screening tools for early detection of cardiovascular diseases and cardiovascular risk factors
WIEN KLIN WOCHENSCHR. 2016; 128: S308-S309.
[Poster]
Web of Science
** Kolesnik, E; Verheyen, N; Krainer, T; Wallner, M; Machler, H; Tomischitz, A; Pilz, S; Brussee, H; von Lewinski, D
Parathyroid hormone (1-34) has no direct effect on human atrial tissue
WIEN KLIN WOCHENSCHR. 2016; 128: S314-S314.
[Poster]
Web of Science
** Verheyen, N; Grubler, M; Fahrleitner-Pammer, A; Pilz, S; Tomaschitz, A; Marz, W
Plasma parathyroid hormone is independently associated with atrial fibrillation - Insights from the LURIC study
WIEN KLIN WOCHENSCHR. 2016; 128: S307-S308.
[Poster]
Web of Science
** Verheyen, N; Manninger, M; Prenner, G; Bisping, E; Brussee, H; Scherr, D; Toth-Gayor, G
Therapy-resistant hypertension in atrial fibrillation - Can bradycardia be the cause?
WIEN KLIN WOCHENSCHR. 2016; 128: S266-S266.
[Poster]
Web of Science
** Verheyen, N; Meinitzer, A; Ablasser, K; Fahrleitner-Pammer, A; Brussee, H; Pilz, S; Tomaschitz, A
Serum kynurenine, quinolinic acid and cardiac stiffness parameters: the eplerenone in primary hyperparathyroidism study
WIEN KLIN WOCHENSCHR. 2016; 128: S308-S308.
[Poster]
Web of Science
** Wetzel, J; Pilz, S; Gruebler, M; Fahrleitner-Pammer, A; Dimai, HP; Von Lewinski, D; Kolesnik, E; Perl, S; Weinrauch, V; Maerz, W; Belyavskiy, E; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, N
Parathyroid hormone is independently associated with systolic blood pressure, pulse wave velocity and left ventricular mass index in patients with primary hyperparathyroidism
EUR HEART J. 2016; 37: 417-417.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY.
[Poster]
Web of Science
** Verheyen, N; Scherr, D; Manninger, M
Letter by Verheyen et al Regarding Article, "Pacemaker Malfunction Attributed to Multidetector Cardiac Computed Tomography".
Circulation. 2016; 134(3):e13-e14
Doi: 10.1161/CIRCULATIONAHA.116.021792
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Catena, C; Colussi, G; Frangipane, A; Russo, A; Verheyen, ND; Sechi, LA
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients.
Nutr Metab Cardiovasc Dis. 2015; 25(10):968-974
Doi: 10.1016/j.numecd.2015.06.009
Web of Science
PubMed
FullText
FullText_MUG
** Catena, C; Verheyen, N; Pilz, S; Kraigher-Krainer, E; Tomaschitz, A; Sechi, LA; Pieske, B
Plasma aldosterone and left ventricular diastolic function in treatment-naïve patients with hypertension: tissue-Doppler imaging study.
Hypertension. 2015; 65(6):1231-1237
Doi: 10.1161/HYPERTENSIONAHA.115.05285
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Gaksch, M; Kienreich, K; Grübler, M; Verheyen, N; Fahrleitner-Pammer, A; Treiber, G; Drechsler, C; Ó, Hartaigh, B; Obermayer-Pietsch, B; Schwetz, V; Aberer, F; Mader, J; Scharnagl, H; Meinitzer, A; Lerchbaum, E; Dekker, JM; Zittermann, A; März, W; Tomaschitz, A
Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.
Hypertension. 2015; 65(6):1195-201
Doi: 10.1161/HYPERTENSIONAHA.115.05319
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Piecha, G; Ritz, E; Meinitzer, A; Haas, J; Pieske, B; Wiecek, A; Rus-Machan, J; Toplak, H; März, W; Verheyen, N; Gaksch, M; Amrein, K; Kraigher-Krainer, E; Fahrleitner-Pammer, A; Pilz, S
Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.
Clin Exp Hypertens. 2015; 37(2):108-15
Doi: 10.3109/10641963.2014.913604
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Verheyen, N; Gaksch, M; Meinitzer, A; Pieske, B; Kraigher-Krainer, E; Colantonio, C; März, W; Schmidt, A; Belyavskiy, E; Rus-Machan, J; van, Ballegooijen, AJ; Stiegler, C; Amrein, K; Ritz, E; Fahrleitner-Pammer, A; Pilz, S
Homoarginine in patients with primary hyperparathyroidism.
Am J Med Sci. 2015; 349(4):306-11
Doi: 10.1097/MAJ.0000000000000419
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Meinitzer, A; Gaksch, M; Grübler, M; Verheyen, N; Drechsler, C; Hartaigh, BÓ; Lang, F; Alesutan, I; Voelkl, J; März, W; Tomaschitz, A
Homoarginine in the renal and cardiovascular systems.
Amino Acids. 2015; 47(9):1703-13
Doi: 10.1007/s00726-015-1993-2
Web of Science
PubMed
FullText
FullText_MUG
** Colantonio, C; Url-Michitsch, M; Verheyen, N; Schutzenhofer, K; Kresoja, K; Kraigher-Krainer, M; Pieske, B; Brussee, H; Schmidt, A
Biomarker to the Early Identification of cardio vascular Ailments; K-Project BioPersMed
WIEN KLIN WOCHENSCHR. 2015; 127: S52-S52.
[Poster]
Web of Science
** Verheyen, N; Wetzel, J; Martensen, J; Belyavskiy, E; Schmidt, A; Colantonio, C; Catena, C; Gaksch, M; Grübler, MR; Kraigher-Krainer, E; Pieske, B; Meinitzer, A; Rus-Machan, J; Fahrleitner-Pammer, A; Pilz, S; Tomaschitz, A
9B.05: ASSOCIATION OF PLASMA PARATHYROID HORMONE WITH NIGHTTIME BLOOD PRESSURE IN PRIMARY HYPERPARATHYROIDISM-THE "EPLERENONE IN PRIMARY HYPERPARATHYROIDISM" TRIAL.
J Hypertens. . 2015; 33 Suppl 1(10):e121-e121.
Doi: 10.1097/01.hjh.0000467677.24307.ad
[Oral Communication]
Web of Science
PubMed
FullText
FullText_MUG
** Grübler, MR; Kienreich, K; Gaksch, M; Verheyen, N; Fahrleitner-Pammer, A; Schmid, J; Grogorenz, J; Ablasser, K; Pieske, B; Tomaschitz, A; Pilz, S
Aldosterone to active renin ratio is associated with nocturnal blood pressure in obese and treated hypertensive patients: the Styrian Hypertension Study.
J Clin Hypertens (Greenwich). 2014; 16(4):289-94
Doi: 10.1111/jch.12274
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** O, Hartaigh, B; Gaksch, M; Kienreich, K; Grübler, MR; Verheyen, N; März, W; Tomaschitz, A; Gill, TM; Pilz, S
Associations of daytime, nighttime, and 24-hour heart rate with four distinct markers of inflammation in hypertensive patients: the Styrian Hypertension Study.
J Clin Hypertens (Greenwich). 2014; 16(12):856-61
Doi: 10.1111/jch.12420
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Kienreich, K; Gaksch, M; Grübler, M; Verheyen, N; Bersuch, LA; Schmid, J; Drechsler, C; Ritz, E; Moosbrugger, A; Stepan, V; Pieber, TR; Meinitzer, A; März, W; Tomaschitz, A
Aldosterone to active Renin ratio as screening test for primary aldosteronism: reproducibility and influence of orthostasis and salt loading.
Horm Metab Res. 2014; 46(6):427-32
Doi: 10.1055/s-0034-1367033
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Ritz, E; Pieske, B; Rus-Machan, J; Kienreich, K; Verheyen, N; Gaksch, M; Grübler, M; Fahrleitner-Pammer, A; Mrak, P; Toplak, H; Kraigher-Krainer, E; März, W; Pilz, S
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Metabolism. 2014; 63(1):20-31
Doi: 10.1016/j.metabol.2013.08.016
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Grubler, MR; Verheyen, N; Gaksch, M; Kienreich, K; Oberreither, E; Schmid, J; Pieske, B; Tomaschitz, A; Pilz, S; Maerz, W
Parathyroid hormone is associated with cardiovascular mortality in patients with acute coronary syndrome
EUR HEART J. 2014; 35: 1157-1157.-Congress of the European-Society-of-Cardiology (ESC); AUG 30-SEP 03, 2014; Barcelona, SPAIN.
[Poster]
Web of Science
** Schmid, J; Kienreich, K; Gaksch, M; Grubler, M; Raggam, R; Meinitzer, A; Rutters, F; Dekker, JM; Marz, W; Verheyen, N; Tomaschitz, A; Pilz, S;
The importance of assays in vitamin D status classification: a comparison of four automated 25-hydroxyvitamin D immunoassays.
LABORATORIUMSMEDIZIN. 2013; 37(5): 261-268.
Doi: 10.1515/labmed-2012-0074
Web of Science
FullText
FullText_MUG
** Tomaschitz, A; Pilz, S; Pieske, B; Ritz, E; März, W; Meinitzer, A; Dobnig, H; Amrein, K; Kienreich, K; Verheyen, N; Kraigher-Krainer, E; Drechsler, C; Colantonio, C; Wagner, D; Fahrleitner-Pammer, A
Circulating aldosterone and mortality in female nursing home residents.
Exp Gerontol. 2013; 48(3):313-318
Doi: 10.1016/j.exger.2013.01.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kienreich, K; Grubler, M; Tomaschitz, A; Schmid, J; Verheyen, N; Rutters, F; Dekker, JM; Pilz, S
Vitamin D, arterial hypertension & cerebrovascular disease.
Indian J Med Res. 2013; 137(4):669-679
[OPEN ACCESS]
Web of Science
PubMed
** Kienreich, K; Tomaschitz, A; Verheyen, N; Pieber, T; Gaksch, M; Grübler, MR; Pilz, S
Vitamin D and cardiovascular disease.
Nutrients. 2013; 5(8):3005-21
Doi: 10.3390/nu5083005
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Verheyen, N; Pilz, S; Eller, K; Kienreich, K; Fahrleitner-Pammer, A; Pieske, B; Ritz, E; Tomaschitz, A
Cinacalcet hydrochloride for the treatment of hyperparathyroidism.
Expert Opin Pharmacother. 2013; 14(6):793-806
Doi: 10.1517/14656566.2013.777041
Web of Science
PubMed
FullText
FullText_MUG
** Grubler, M; Kienreich, K; Tomaschitz, A; Verheyen, N; Gaksch, M; Fahrleitner-Pammer, A; Schmid, J; Pieske, B; Pieber, TR; Pilz, S;
Aldosterone to renin ratio is associated with 24 hour ambulatory blood pressure in essential hypertensives: the Styrian Hypertension study.
EUR HEART J. 2013; 34: 1051-1051.-Congress of the European-Society-of-Cardiology (ESC); AUG 31-SEP 04, 2013; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Grubler, MR; Verheyen, N; Pilz, S; Kienreich, K; Gaksch, M; Schmid, J; Rus-Machan, J; Fahrleitner-Pammer, A; Kraigher-Krainer, E; Pieske, B; Marz, W; Tomaschitz, A
Is Resting Heart Rate Really Associated With Cardiovascular Mortality?
CIRCULATION. 2013; 128(22):
[Poster]
Web of Science
FullText
** Grubler, MR; Verheyen, N; Tomaschitz, A; Kienreich, K; Gaksch, M; Bersuch, LA; Fahrleitner-Pammer, A; Schmid, J; Marz, W; Pieske, B; Pilz, S
Nocturnal Diastolic Blood Pressure is Associated With 24 Hour Urinary Albumin in Essential Hypertensive Patients
CIRCULATION. 2013; 128(22):
[Oral Communication]
Web of Science
FullText
** Verheyen, N; Grubler, M; Pilz, S; Kienreich, K; Gaksch, M; Schmid, J; Bersuch, LA; Pieske, B; Kraigher-Krainer, E; Fahrleitner-Pammer, A; Boehm, BO; Marz, W; Tomaschitz, A
Serum Parathyroid Hormone is Independently Associated With Atrial Fibrillation: Insights From the LURIC Study
CIRCULATION. 2013; 128(22):
[Poster]
Web of Science
FullText
** Kienreich, K; Tomaschitz, A; Verheyen, N; Pieber, TR; Pilz, S
Vitamin D and arterial hypertension: treat the deficiency!
Am J Hypertens. 2013; 26(2):158-158
Doi: 10.1093/ajh/hps058
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tomaschitz, A; Fahrleitner-Pammer, A; Pieske, B; Verheyen, N; Amrein, K; Ritz, E; Kienreich, K; Horina, JH; Schmidt, A; Kraigher-Krainer, E; Colantonio, C; Meinitzer, A; Pilz, S
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.
BMC Endocr Disord. 2012; 12(12):19-19
Doi: 10.1186/1472-6823-12-19
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG